TY - JOUR
T1 - Gamma-delta T lymphocytes in the diagnostic approach of coeliac disease
AU - Nijeboer, Petula
AU - van Gils, Tom
AU - Reijm, Martine
AU - Ooijevaar, Rogier
AU - Lissenberg-Witte, Birgit I.
AU - Bontkes, Hetty J.
AU - Mulder, Chris J. J.
AU - Bouma, Gerd
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Goals: To validate cut-off values of CD 3+ T-cell receptor gammadelta chain (TCRγδ + ) intraepithelial lymphocyte (IEL) in the (differential) diagnosis of celiac disease (CD). Background: CD is characterized by an increase in gamma-delta IEL (CD 3+ TCRγδ + IEL). Study: Percentages were determined by flow cytometric analysis of IELs from small bowel biopsies in 213 CD and 13 potential CD (PCD) patients and in total 112 controls. A cut-off value for percentages of CD 3+ TCRγδ + IEL to differentiate active CD and controls was obtained from a receiver operating characteristic curve and implemented in controls and PCD patients. Results: Percentage of CD 3+ TCRγδ + IEL was significantly increased in the majority of CD patients, irrespective of the presence of villous atrophy. A cut-off value of 14% for CD 3+ TCRγδ + IEL resulted in 66.3% sensitivity and 96.6% specificity for CD diagnosis (area under the curve, 88.6%). Conclusions: A percentage of ≥14% CD 3+ TCRγδ + IEL has a high specificity for CD diagnosis and can be of diagnostic help in cases where diagnosis is not straightforward.
AB - Goals: To validate cut-off values of CD 3+ T-cell receptor gammadelta chain (TCRγδ + ) intraepithelial lymphocyte (IEL) in the (differential) diagnosis of celiac disease (CD). Background: CD is characterized by an increase in gamma-delta IEL (CD 3+ TCRγδ + IEL). Study: Percentages were determined by flow cytometric analysis of IELs from small bowel biopsies in 213 CD and 13 potential CD (PCD) patients and in total 112 controls. A cut-off value for percentages of CD 3+ TCRγδ + IEL to differentiate active CD and controls was obtained from a receiver operating characteristic curve and implemented in controls and PCD patients. Results: Percentage of CD 3+ TCRγδ + IEL was significantly increased in the majority of CD patients, irrespective of the presence of villous atrophy. A cut-off value of 14% for CD 3+ TCRγδ + IEL resulted in 66.3% sensitivity and 96.6% specificity for CD diagnosis (area under the curve, 88.6%). Conclusions: A percentage of ≥14% CD 3+ TCRγδ + IEL has a high specificity for CD diagnosis and can be of diagnostic help in cases where diagnosis is not straightforward.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064411292&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/29782465
U2 - https://doi.org/10.1097/MCG.0000000000001060
DO - https://doi.org/10.1097/MCG.0000000000001060
M3 - Article
C2 - 29782465
SN - 0192-0790
VL - 53
SP - E208-E213
JO - Journal of clinical gastroenterology
JF - Journal of clinical gastroenterology
IS - 5
ER -